Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Sang Yu

Showing results (141-150 of 349) with videos related to

Pageof 35
Sort By:
Drug Design, Development and Therapy|August 26, 2014
Predictive performance of gentamicin dosing nomogramsJieon Lee, Seonghae Yoon, Donghoon Shin, et al.
Scientific Reports|March 19, 2021
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsyYoonhyuk Jang, Seonghae Yoon, Tae-Joon Kim, et al.
Nephrology (Carlton, Vic.)|December 24, 2010
Clinical usefulness of serum cystatin C and the pertinent estimation of glomerular filtration rate based on cystatin CRan-Hui Cha, Chung Sik Lee, Youn-Hee Lim, et al.
Journal of Cardiovascular Pharmacology|March 12, 2011
Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteersSoJeong Yi, Tae-Eun Kim, Seo Hyun Yoon, et al.
Scientific Reports|May 5, 2022
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertensionSu-Jin Rhee, Seung Han Shin, Jaeseong Oh, et al.
Clinical Pharmacology in Drug Development|April 22, 2021
Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean SubjectsMu Seong Ban, Yun Kim, Sunyoung Lee, et al.
Cancers|October 9, 2019
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from CirrhosisDa Jung Kim, Eun Ju Cho, Kyung-Sang Yu, et al.
Therapeutic Drug Monitoring|October 29, 2025
Evaluation of the Real-World Practice of Model-Informed Therapeutic Drug Monitoring and Its Association With Pharmacokinetic Target Attainment Rates: A Large-Scale, Single-Center Retrospective StudyYoonjin Kim, Jaegu Kang, Jisoo Song, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2017
The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-Density LipoproteinTae-Eun Kim, Dongseong Shin, Namyi Gu, et al.
Scientific Reports|December 21, 2019
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjectsYun Kim, Seonghae Yoon, Yewon Choi, et al.
Pageof 35

Showing results (141-150 of 349) with videos related to

Sort By:
Pageof 35
Drug Design, Development and Therapy|August 26, 2014
Predictive performance of gentamicin dosing nomogramsJieon Lee, Seonghae Yoon, Donghoon Shin, et al.
Scientific Reports|March 19, 2021
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsyYoonhyuk Jang, Seonghae Yoon, Tae-Joon Kim, et al.
Nephrology (Carlton, Vic.)|December 24, 2010
Clinical usefulness of serum cystatin C and the pertinent estimation of glomerular filtration rate based on cystatin CRan-Hui Cha, Chung Sik Lee, Youn-Hee Lim, et al.
Journal of Cardiovascular Pharmacology|March 12, 2011
Pharmacokinetic interaction of fimasartan, a new angiotensin II receptor antagonist, with amlodipine in healthy volunteersSoJeong Yi, Tae-Eun Kim, Seo Hyun Yoon, et al.
Scientific Reports|May 5, 2022
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertensionSu-Jin Rhee, Seung Han Shin, Jaeseong Oh, et al.
Clinical Pharmacology in Drug Development|April 22, 2021
Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean SubjectsMu Seong Ban, Yun Kim, Sunyoung Lee, et al.
Cancers|October 9, 2019
Comprehensive Metabolomic Search for Biomarkers to Differentiate Early Stage Hepatocellular Carcinoma from CirrhosisDa Jung Kim, Eun Ju Cho, Kyung-Sang Yu, et al.
Therapeutic Drug Monitoring|October 29, 2025
Evaluation of the Real-World Practice of Model-Informed Therapeutic Drug Monitoring and Its Association With Pharmacokinetic Target Attainment Rates: A Large-Scale, Single-Center Retrospective StudyYoonjin Kim, Jaegu Kang, Jisoo Song, et al.
Basic & Clinical Pharmacology & Toxicology|June 20, 2017
The Effect of Genetic Polymorphisms in SLCO2B1 on the Lipid-Lowering Efficacy of Rosuvastatin in Healthy Adults with Elevated Low-Density LipoproteinTae-Eun Kim, Dongseong Shin, Namyi Gu, et al.
Scientific Reports|December 21, 2019
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjectsYun Kim, Seonghae Yoon, Yewon Choi, et al.
Pageof 35